Blood test to guide radiation for rectal cancer
Part of Cancer, Digestive system clinical trials.
This study tests a simple blood test to find out early whether your rectal cancer might not respond well to radiation therapy. If the test works, doctors could adjust your treatment to avoid unnecessary side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with rectal cancer (a type called adenocarcinoma).
- Your treatment plan includes chemotherapy and radiation before surgery (neoadjuvant chemoradiation).
- You are not scheduled to receive a different treatment plan, such as chemotherapy alone or a short course of radiation.
- You can read and understand Dutch, and are mentally able to participate.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test (called MRD) after surgery to see if any tiny bits of cancer DNA are left. It helps doctors decide whether extra chemotherapy is needed or if it can be safely skipped, and it may reduce unnecessary side effects.
This study looks at whether a genetic test on a small sample of your tumor can predict how well you will respond to chemotherapy and radiation before surgery. This might help doctors choose the best treatment for you.
This trial is looking at whether a simple blood test (ctDNA monitoring) can help predict how well total neoadjuvant therapy (chemo and radiation before surgery) works for rectal cancer. It may help doctors tailor treatment to your specific needs.
This trial uses a special DNA blood test (circulating tumor DNA) to help guide chemotherapy and radiation before surgery for locally advanced rectal cancer. It aims to improve outcomes by tailoring treatment based on the DNA signals from the tumor.
This study looks at whether a blood test that finds tumor DNA can help doctors choose the best treatment for rectal cancer, possibly allowing some patients to avoid surgery. It tests different chemotherapy and radiation combinations to see if the cancer disappears completely.
This trial tests whether checking for tumor DNA in your blood after surgery can help decide if you need additional chemotherapy. If the test finds cancer DNA, you may get chemo to lower the risk of the cancer coming back.
Hear when a new Pathological Response Rate, Circulating Tumour DNA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.